Advancing the field of cancer immunotherapy: MIATA consensus guidelines become available to improve data reporting and interpretation for T-cell immune monitoring

by Hoos, Axel, Janetzki, Sylvia, Britten, Cedrik M.
Published 2012

A framework for T cell assays

by Britten, Cedrik M., van der Burg, Sjoerd H., Gouttefangeas, Cécile
Published in Oncotarget (2015)

Report on the Fifth Annual Meeting of the Association for Immunotherapy of Cancer (CIMT) April 12–14, 2007 in Würzburg, Germany

by Welters, Marij J. P., Gouttefangeas, Cécile, Attig, Sebastian, Koch, Sven, Britten, Cedrik M.
Published 2007

Greater patient access to immuno-oncology therapies—what can policymakers do?

by de Lorenzo, Francesco, Wait, Suzanne, Karaca, Burçak, Britten, Cedrik M, van den Bulcke, Marc
Published in Ecancermedicalscience (2015)

Structured reporting of T cell assay results

by Janetzki, Sylvia, Hoos, Axel, Melief, Cornelis J.M., Odunsi, Kunle, Romero, Pedro, Britten, Cedrik M.
Published 2013

Orchestrating an immune response against cancer with engineered immune cells expressing αβTCRs, CARs, and innate immune receptors: an immunological and regulatory challenge

by de Witte, Moniek A., Kierkels, Guido J. J., Straetemans, Trudy, Britten, Cedrik M., Kuball, Jürgen
Published in Cancer Immunol Immunother (2015)

Harmonization of the intracellular cytokine staining assay

by Welters, Marij J. P., Gouttefangeas, Cécile, Ramwadhdoebe, Tamara H., Letsch, Anne, Ottensmeier, Christian H., Britten, Cedrik M., van der Burg, Sjoerd H.
Published 2012

Response definition criteria for ELISPOT assays revisited

by Moodie, Z., Price, L., Gouttefangeas, C., Mander, A., Janetzki, S., Löwer, M., Welters, M. J. P., Ottensmeier, C., van der Burg, S. H., Britten, Cedrik M.
Published 2010

Cryopreservation of MHC Multimers: Recommendations for Quality Assurance in Detection of Antigen Specific T Cells

by Hadrup, Sine Reker, Maurer, Dominik, Laske, Karoline, Frøsig, Thomas Mørch, Andersen, Sofie Ramskov, Britten, Cedrik M, van der Burg, Sjoerd H, Walter, Steffen, Gouttefangeas, Cécile
Published in Cytometry A (2015)

A Harmonized Approach to Intracellular Cytokine Staining Gating: Results from an International Multiconsortia Proficiency Panel Conducted by the Cancer Immunotherapy Consortium (CI...

by McNeil, Lisa K., Price, Leah, Britten, Cedrik M., Jaimes, Maria, Maecker, Holden, Odunsi, Kunle, Matsuzaki, Junko, Staats, Janet S., Thorpe, Jerill, Yuan, Jianda, Janetzki, Sylvia
Published in Cytometry A (2013)

A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

by Attig, Sebastian, Price, Leah, Janetzki, Sylvia, Kalos, Michael, Pride, Michael, McNeil, Lisa, Clay, Tim, Yuan, Jianda, Odunsi, Kunle, Hoos, Axel, Romero, Pedro, Britten, Cedrik M
Published 2011

“MIATA”—Minimal Information about T Cell Assays

by Janetzki, Sylvia, Britten, Cedrik M., Kalos, Michael, Levitsky, Hyam I., Maecker, Holden T., Melief, Cornelius J.M., Old, Lloyd J., Romero, Pedro, Hoos, Axel, Davis, Mark M.
Published 2009

Hierarchical Modeling for Rare Event Detection and Cell Subset Alignment across Flow Cytometry Samples

by Cron, Andrew, Gouttefangeas, Cécile, Frelinger, Jacob, Lin, Lin, Singh, Satwinder K., Britten, Cedrik M., Welters, Marij J. P., van der Burg, Sjoerd H., West, Mike, Chan, Cliburn
Published 2013

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

by Janetzki, Sylvia, Panageas, Katherine S., Ben-Porat, Leah, Boyer, Jean, Britten, Cedrik M., Clay, Timothy M., Kalos, Michael, Maecker, Holden T., Romero, Pedro, Yuan, Jianda, Martin Kast, W., Hoos, Axel
Published 2007

Managing Multi-center Flow Cytometry Data for Immune Monitoring

by White, Scott, Laske, Karoline, Welters, Marij JP, Bidmon, Nicole, van der Burg, Sjoerd H, Britten, Cedrik M, Enzor, Jennifer, Staats, Janet, Weinhold, Kent J, Gouttefangeas, Cécile, Chan, Cliburn
Published in Cancer Inform (2015)

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

by Mandruzzato, Susanna, Brandau, Sven, Britten, Cedrik M., Bronte, Vincenzo, Damuzzo, Vera, Gouttefangeas, Cécile, Maurer, Dominik, Ottensmeier, Christian, van der Burg, Sjoerd H., Welters, Marij J. P., Walter, Steffen
Published in Cancer Immunol Immunother (2016)

Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols

by Filbert, Helene, Attig, Sebastian, Bidmon, Nicole, Renard, Bernhard Y., Janetzki, Sylvia, Sahin, Ugur, Welters, Marij J. P., Ottensmeier, Christian, van der Burg, Sjoerd H., Gouttefangeas, Cécile, Britten, Cedrik M.
Published 2012

SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: Online resources and useful tools - a compass in the land of biomarker discovery

by Bedognetti, Davide, Balwit, James M, Wang, Ena, Disis, Mary L, Britten, Cedrik M, Delogu, Lucia G, Tomei, Sara, Fox, Bernard A, Gajewski, Thomas F, Marincola, Francesco M, Butterfield, Lisa H
Published 2011

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters

by Gouttefangeas, Cécile, Chan, Cliburn, Attig, Sebastian, Køllgaard, Tania T., Rammensee, Hans-Georg, Stevanović, Stefan, Wernet, Dorothee, thor Straten, Per, Welters, Marij J. P., Ottensmeier, Christian, van der Burg, Sjoerd H., Britten, Cedrik M.
Published in Cancer Immunol Immunother (2015)

The development of standard samples with a defined number of antigen-specific T cells to harmonize T cell assays: a proof-of-principle study

by Singh, Satwinder Kaur, Tummers, Bart, Schumacher, Ton N., Gomez, Raquel, Franken, Kees L. M. C., Verdegaal, Els M., Laske, Karoline, Gouttefangeas, Cécile, Ottensmeier, Christian, Welters, Marij J. P., Britten, Cedrik M., van der Burg, Sjoerd H.
Published 2012